Esserre Pharma è un'Azienda con sede a Roma, impegnata nella ricerca scientifica di materie prime selezionate... Esserre Pharma; Monitorare le vendite presso le Farmacie del territorio assegnato; Sales Reporting. Offriamo...
Esserre Pharma è un'Azienda con sede a Roma, impegnata nella ricerca scientifica di materie prime selezionate... con la categoria professionale dei Nutrizionisti; Offrire consulenza scientifica in merito ai prodotti Esserre Pharma; Monitorare le...
Esserre Pharma, Azienda impegnata nella ricerca, nello sviluppo e nella distribuzione di prodotti nutraceutici Evidence... e seleziona un responsabile dello sviluppo del Business Esserre Pharma. La risorsa selezionata si occuperà nel dettaglio di...
The trends on Gift Nifty also indicate a positive start for the Indian benchmark index. The Gift Nifty was trading around 22,890 level, a premium of nearly 115 points from the Nifty futures’ previous close. Continue Reading »
Indian stock market: Gift Nifty was trading around the 22,900 level, a premium of nearly 125 points from the Nifty futures’ previous close, indicating a positive start for the Indian stock market indices. Continue Reading »
Crude prices came under pressure after US data pointed to persistent labour market strength which further dimmed prospects of an early decline in US interest rates. Continue Reading »
Freshworks now expects annual revenue between $695 million and $705 million, compared with its previous forecast of $703.5 million to $711.5 million. Continue Reading »
While gold is traditionally considered a hedge against inflation, high interest rates kept by the US Fed to tame the rising prices can increase the opportunity cost of holding the non-yielding bullion. Continue Reading »
Manpansand Beverages' top officials have been asked to pay penalties totaling ₹74 lakh by SEBI for violations including misstating and manipulating financial statements. Continue Reading »
Stock Market Today- Cipla, Aurobindo, Torrent are 3 preferred picks of HSBC Research on healthy Q4 expectations. HSBC expects 38.4% y-o-y rise in net profit of pharma companies in their coverage during Q4 helped by rising US sales compensating for slower growth in India Continue Reading »